1. Home
  2. AHCO vs WGS Comparison

AHCO vs WGS Comparison

Compare AHCO & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AdaptHealth Corp.

AHCO

AdaptHealth Corp.

HOLD

Current Price

$10.84

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$59.87

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AHCO
WGS
Founded
2012
2017
Country
United States
United States
Employees
N/A
1300
Industry
Medical/Nursing Services
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
AHCO
WGS
Price
$10.84
$59.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$13.50
$120.71
AVG Volume (30 Days)
1.3M
720.6K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,244,857,000.00
N/A
Revenue This Year
$9.00
$29.98
Revenue Next Year
$6.93
$25.92
P/E Ratio
N/A
$1,251.58
Revenue Growth
N/A
N/A
52 Week Low
$8.51
$32.21
52 Week High
$13.43
$170.87

Technical Indicators

Market Signals
Indicator
AHCO
WGS
Relative Strength Index (RSI) 55.80 46.32
Support Level $10.80 $55.76
Resistance Level $12.87 $63.31
Average True Range (ATR) 0.40 4.22
MACD 0.05 -0.95
Stochastic Oscillator 55.61 16.06

Price Performance

Historical Comparison
AHCO
WGS

About AHCO AdaptHealth Corp.

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: